Related Experiment Video
Updated: Aug 21, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
[The latest trends in the treatment peritonitis of the patients on peritoneal dialysis]
Abstract:
Peritonitis is still one of the major complications ambulatory peritoneal dialysis (CAPD). The initial empiric therapy for peritonitis should be effective against most grampositive organisms as well as gramnegative organisms. Intraperitoneal administration antibiotics has the advantage of a high concentration of the antibiotics at the site of infection. The treatment should provide broad coverage of all organisms, without side-effects or risk for the patient and should not provoke the emergence of resistant germs. The present guidelines of the ad hoc advisory committee are of great value in this regard. The ISPD guidelines for treatment of peritonitis recommended an empirical therapy based on the association of a first-generation cephalosporin with an aminoglycoside or ceftazidime.
Insights
Peritonitis is a major complication of continuous ambulatory peritoneal dialysis (CAPD). Current guidelines recommend empirical antibiotic therapy combining a cephalosporin with an aminoglycoside or ceftazidime for effective treatment.
Area of Science:
- Nephrology
- Infectious Diseases
- Pharmacology
Context:
- Peritonitis remains a significant complication in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
- Effective management requires empirical antibiotic therapy targeting common Gram-positive and Gram-negative pathogens.
- Intraperitoneal antibiotic administration offers localized high drug concentrations at the infection site.
Purpose:
- To outline optimal empirical antibiotic strategies for CAPD-associated peritonitis.
- To ensure broad-spectrum coverage while minimizing patient side effects and resistance development.
- To align treatment recommendations with established International Society for Peritoneal Dialysis (ISPD) guidelines.
Summary:
- Empirical therapy for CAPD peritonitis should cover both Gram-positive and Gram-negative organisms.
- Intraperitoneal antibiotics provide a therapeutic advantage due to high local concentrations.
- ISPD guidelines suggest combining a first-generation cephalosporin with either an aminoglycoside or ceftazidime.
Impact:
- Provides evidence-based recommendations for managing a common and serious complication of CAPD.
- Aims to improve treatment outcomes and reduce the incidence of antibiotic resistance.
- Supports clinicians in selecting appropriate initial antibiotic regimens for peritonitis.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Acute Kidney Injury V: Interprofessional Care
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Pyelonephritis II: Diagnostic Studies and Management

